Sort   by:  
 Page size 
UnknownBeyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting.
Not available
S-EPMC10813411 | biostudies-literature
UnknownMultimodal histopathologic models stratify hormone receptor-positive early breast cancer.
Not available
S-EPMC11873197 | biostudies-literature
UnknownComprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial.
Not available
S-EPMC12242418 | biostudies-literature
UnknownCirculating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial.
Not available
S-EPMC7373944 | biostudies-literature
UnknownComprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial.
Not available
S-EPMC11964631 | biostudies-literature
UnknownIdentifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
Not available
S-EPMC8780351 | biostudies-literature
UnknownThe Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus.
Not available
S-EPMC10388578 | biostudies-literature
UnknownComparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors.
Not available
S-EPMC12152862 | biostudies-literature
Sort   by:  
 Page size